HER2-Positive Gastric Cancer

被引：0
|
作者：
Haralabos Demetriades
机构：
[1] Aristotle University of Thessaloniki,4th Surgical Department
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Gastric Cancer; Trastuzumab; Gastric Cancer Patient; Adjuvant Setting; HER2 Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：1
相关论文
共 50 条
  • [31] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
    Mueller, Volkmar
    Clemens, Michael
    Jassem, Jacek
    Al-Sakaff, Nedal
    Auclair, Petra
    Nuesch, Eveline
    Holloway, Debbie
    Shing, Mona
    Bang, Yung-Jue
    BMC CANCER, 2018, 18
  • [32] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
    Volkmar Müller
    Michael Clemens
    Jacek Jassem
    Nedal Al-Sakaff
    Petra Auclair
    Eveline Nüesch
    Debbie Holloway
    Mona Shing
    Yung-Jue Bang
    BMC Cancer, 18
  • [33] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    LANCET, 2017, 389 (10087): : 2415 - 2429
  • [34] HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer
    Lordick, F.
    Bang, Y. J.
    Kang, Y. K.
    Otero Reyes, D.
    Manikhas, G. M.
    Shen, L.
    Kulikov, E.
    Stoss, O.
    Jordan, B. W. M.
    Van Cutsem, E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 272 - 272
  • [35] Cerebrospinal Fluid Cytology Diagnosis of HER2-Positive Leptomeningeal Carcinomatosis From HER2-Positive Metastatic Gastric Cancer: Case Report
    Cavanna, Luigi
    Rocchi, Andrea
    Gorgni, Silvia
    Ambroggi, Massimo
    Foroni, Raoul P.
    Ubbiali, Alessandro
    Civardi, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : E367 - E368
  • [36] NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer
    Holden, Joanne
    Garrett, Zoe
    Stevens, Andrew
    LANCET ONCOLOGY, 2011, 12 (01): : 16 - 17
  • [37] Survival of patients with HER2-positive gastric cancer with introduction of trastuzumab.
    Shitara, Kohei
    Yatabe, Yasushi
    Sugano, Masato
    Matsuo, Keitaro
    Kondo, Chihiro
    Takahari, Daisuke
    Ura, Takashi
    Tajika, Masahiro
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
    Oh, Do-Youn
    Lee, Kewn-Wook
    Cho, Jae Yong
    Kang, Won Ki
    Im, Seock-Ah
    Kim, Jin Won
    Bang, Yung-Jue
    GASTRIC CANCER, 2016, 19 (04) : 1095 - 1103
  • [39] Second line of treatment for HER2-positive gastric cancer: an evolving issue
    Roviello, Giandomenico
    Catalano, Martina
    D'Angelo, Alberto
    Palmieri, Valeria Emma
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (02) : 316 - 317
  • [40] HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies
    Pous, Anna
    Notario, Lucia
    Hierro, Cinta
    Layos, Laura
    Buges, Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
12345